Fortrea Holdings Inc. FTRE
Fortrea, LabCorp's spun-out CRO, earns 9% EBITDA margins versus 18% peers; CEO Tom Pike's IQVIA playbook implies $47-$72 per share, 60-144% upside at normalized margins.
Thesis
Fortrea Holdings is a $4bn enterprise-value global contract research organization spun out from LabCorp in 2023, with ~$3bn FY23 revenue, 90+ country footprint, and roughly 7% share of a concentrated CRO market set to grow ~7% annually through 2027. Despite scale comparable to peers like ICON, PPD, and Syneos, Fortrea's FY23 adjusted EBITDA margin guide of 9% sits well below the peer median of 18-19% at comparable scale, reflecting stranded spin-related costs and operational slack that management has pledged to close as TSAs roll off by end-FY24. CEO Tom Pike previously ran Quintiles/IQVIA, where he expanded adjusted EBITDA margins ~425bps and delivered 48% S&P 500 outperformance. Starboard argues that at peer-median 13x EV/EBITDA and normalized margins, Fortrea is worth ~$47 per share at FY24 exit margins (60% upside) or ~$72 at peer margins (144% upside) versus the $29.46 reference price.
SCQA
Fortrea is a global contract research organization spun out from LabCorp in 2023 with $3bn revenue and 7% share of a concentrated CRO market poised for durable 7% annual growth.
Fortrea's 9% FY23 EBITDA margin guide lags the 18-19% peer median, driven by post-spin stranded costs and operational slack that roll-off of TSAs and basic execution can close.
Support management's margin-improvement roadmap under CEO Tom Pike, who repeated a similar margin playbook at Quintiles/IQVIA, and let operational execution drive rerating toward peer benchmarks.
At peer-median 13x EV/EBITDA, normalized margins imply ~$47 per share at FY24 exit margins (60% upside) or ~$72 at peer margins (144% upside) from $29.46.
The three reasons
- 1
Fortrea's 9% FY23 EBITDA margin lags CRO peer median of 18-19%
- 2
CEO Tom Pike grew IQVIA margins 425bps and delivered 48% S&P outperformance
- 3
Peer multiples imply ~60-144% upside ($47-$72) at normalized margins
Primary demands
- Execute on management's stated plan to return to FY22 peer-comparable profitability by end of FY24
- Drive EBITDA margins from 9% FY23 guide toward the 18% peer median at comparable scale
- Leverage CEO Tom Pike's proven CRO margin-improvement playbook to unlock multiple rerating
KPIs cited
Pattern membership
Where this document fits across the library's 12 rhetorical / structural patterns.
Precedents cited
- Tom Pike's Quintiles/IQVIA margin expansion (FY12-LTM Sept 2016, +425bps)
- CRO M&A precedents (LabCorp/Covance, Thermo/PPD, ICON/PRA, EQT/Parexel, PE/Syneos)
Notable slides (5)
Notes
Unusually collaborative/supportive Starboard deck: no villain, no adversarial demand — Starboard endorses incumbent CEO Tom Pike and management's existing margin plan, positioning itself as a validating shareholder. CEO quote on page 12 is used to reinforce (not contradict) the thesis. No stake disclosed in this conference presentation. Filename contains '2023-02-2023' which appears to be a file-naming artifact; deck cover and internal references date the document to October 2023 (Active-Passive Investor Summit).